Aspergillosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019GlobalDataMarch 31, 2012 63 Pages - SKU: GBDT3865549 |
More Drug Discovery reports by GlobalData
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 by GlobalData
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017SummaryCystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky ...
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017 by GlobalData
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017SummaryIdiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. ...
Radiculopathy Global Clinical Trials Review, H1, 2013 by GlobalData
Radiculopathy Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2013 provides data on the Radiculopathy clinical trial scenario. ...
Dystonia Global Clinical Trials Review, H1, 2013 by GlobalData
See all reports like this >>Dystonia Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2013 provides data on the Dystonia clinical trial scenario. ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports
